The Story Of Our Firm | En Español
FONT SIZE: A A A A A

Drugs & Medical Devices

Vioxx

in this section: W&L Press Release, 6/07 - Vioxx Reversal | $13.5 Million Vioxx Trial Verdict | Research Center | FREE Legal Review | Questionnaire


Bookmark This Page Print This Page Email This Page


BREAKING NEWS: April 25, 2008--A Class I recall was issued by Actavis Totowa LLC for all lots of the heart medicine Digitek (generic name digoxin) because some have been found to contain twice the approved levels of active ingredient than is appropriate. Read on for more.

Vioxx Lawsuit Information: Weitz & Luxenberg Wins Second Vioxx Case



BREAKING NEWS: November 9, 2007 -- After pulling pain killer Vioxx from the market three years ago, Merck says it will pay $4.85 billion to settle 27,000 suits involving people who were injured or died after ingesting the drug.

Vioxx lawsuit

Vioxx was supposed to be the 'super aspirin' that would relieve pain safely.

Instead, Vioxx was recalled because it increased the risk of heart attacks and strokes.

For a Vioxx lawsuit, you will need a law firm with a proven record of success in the Vioxx litigation. Weitz & Luxenberg is the law firm that won the second lawsuit against Merck for a Vioxx heart attack victim in Atlantic City, a jury verdict of $13.5 Million.

An experienced Vioxx lawyer/attorney from Weitz & Luxenberg can help you file a lawsuit to get compensation for your injuries. We'll worry about the legal deadlines; you focus on feeling better. Our short form below will start the process.

Major Verdict: $13.5 million dollar jury verdict in one of the first Vioxx Trial cases - "a victory for the 100,000 Americans who had heart attacks from Vioxx," says W&L lawyer Robert Gordon.

your next step . . .

Fill out a form for a
free case review

Learn more about
Vioxx dangers

Call us:
(800) 476-6070

Weitz & Luxenberg is no longer accepting Vioxx cases.


see also:

FREE Legal Review Affected by Vioxx? The right law firm can help: Weitz and Luxenberg
Weitz & Luxenberg: Winning law firm of second Vioxx lawsuit vs Merck

$13.5 Million Vioxx Trial Verdict New Jersey Vioxx Trial - $13.5 Million Vioxx Trial Verdict
Vioxx Trial - Weitz & Luxenberg wins $13.5 million verdict for client.

Advanced Bionics Advanced Bionics Under Heat for Health Risk to Some Cochlear Implants
Lawyer fluent in ASL can discuss your potential Advanced Bionics case
Free Legal Review
Name:
Phone:
Email:
Case Description:
$423 million settlement— MTBE suit involving the contamination of 153 public water systems nationally

$16.5 million verdict — Asbestos case involving exposure from dental tape

$1.4 million settlement — Accident involving woman struck down by ambulance

$1.5 million settlement — for 47-year-old construction worker who fell off elevated train tracks

$6 million settlement — Pediatric malpractice involving infant who suffered brain damage at birth

$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims



Ask a Free Question:
Were you injured?

check for your response [login]
For legal help anywhere in the U.S.
A nationally-recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases, get the compensation to which they’re entitled and continue with their lives. In just over 20 years, we’ve collected more than $1.3 billion for plaintiffs.